From ISO 9001:2015 to ISO 20387:2018: a proposed implementation roadmap for biobanks

Biobanks play an important role in biomedical research because of the availability of vast quantities of high-quality biological specimens and related data. However, biobank-specific standards such as ISO 20387:2018 have been infrequently implemented. This study aimed to develop a practical implementation roadmap to assist ISO 9001:2015-certified biobanks in adopting ISO 20387:2018.

The implementation roadmap was developed through a scientific literature review and a comparative, clause-level analysis (crosswalk) of ISO 9001:2015 and ISO 20387:2018. The analysis identified areas of overlap between the standards and requirements specific to ISO 20387:2018.

The crosswalk demonstrated substantial overlap between the two standards while identifying additional ISO 20387:2018 requirements related to financial viability assessment, plans for future expansion, additional specimen-collection standards, authentication protocols, and reporting requirements. Based on these findings, we developed a practical, time-bound implementation framework that leverages existing ISO 9001:2015 systems to help structure the transition to ISO 20387:2018. The proposed roadmap can be completed within an estimated 17-20 weeks.

The implementation framework provides a structured approach for ISO 9001:2015-certified biobanks seeking to adopt ISO 20387:2018 and may help make accreditation more attainable for resource-constrained biobanks. We identify testable assumptions about feasibility, duration, and organizational benefits, and highlight the need for formal training in biobank management to sustain implementation. Prospective validation is needed to determine whether the proposed timeline and anticipated organizational benefits are achieved in practice.